Pharmacy Market To Reach US$ 1,750 Billion By 2032

Introduction

Global Pharmacy Market size is expected to be worth around US$ 1,750 Billion by 2032 from US$ 1,161 Billion in 2023, growing at a CAGR of 4.8% during the forecast period from 2024 to 2032. With a market share over 52.2%, North America held a strong lead in 2023, reaching US$ 577.2 Billion in revenue.

Pharmacies are central to providing medications and select over-the-counter medical devices. The pharmacy sector is evolving rapidly due to increasing healthcare demands, the prevalence of chronic diseases, and advancements in pharmaceutical research and technology. Market growth is further supported by rising demand for personalized medicine, the expansion of generic drug availability, and the proliferation of online pharmacies.

Despite these advancements, challenges such as stringent regulatory requirements, high research and development costs for drug innovation, and pricing pressures remain significant. However, opportunities abound in areas such as digital health solutions, telehealth adoption, preventive care demand, and market expansion in developing regions.

According to the U.S. Department of Health, approximately 133 million Americans are living with at least one chronic disease. To address these needs, pharmacies both independent and chain stores provide a diverse range of prescription medications, over-the-counter drugs, medical devices, and wellness products. Many pharmacies now serve as comprehensive “one-stop shops,” offering pharmacy products alongside essentials like skincare, baby care, and household items.

Recent trends highlight a growing focus on personalization, sustainability, and the expansion of online pharmacies. Pharmacies are increasingly adopting automation and digitalization to boost operational efficiency, improve patient safety, and deliver personalized services. The COVID-19 pandemic accelerated this transformation, as pharmacies expanded their roles to include testing and vaccination services. For instance, in July 2024, Babson Diagnostics introduced blood testing services through retail pharmacies like Peoples Rx and Lake Hills Pharmacy in Texas.

Pharmacists are also enhancing their offerings with services such as glucose testing, cholesterol screening, and immunizations at community pharmacies. Loyalty programs are gaining traction in improving customer engagement, with 33% of U.S. consumers enrolling in new programs in 2022. Globally, 57% of consumers redeemed loyalty points in 2022 to save money, while 60% valued personalized offers. These trends underscore the importance of tailored interactions to foster customer loyalty and drive savings.

Key Takeaways

• Market Overview: The global pharmacy market is expanding, with a projected CAGR of 4.8% due to demographic shifts and health trends.
• Growth Drivers: Increases in the aging population, prescription volumes, and disease prevalence are major factors propelling market growth.
• England’s Spending: In fiscal year 2020-2021, England saw a 3.5% rise in medication expenditures, reflecting growing healthcare demands.
• Dominant Segment: Prescription medications lead the market, supported by an aging population and rising chronic diseases like diabetes and heart disease.
• OTC Growth: The OTC segment is set to grow fastest, fueled by demand for analgesics, heartburn, and respiratory treatments.
• Retail Pharmacies: In 2022, retail pharmacies dominated due to increased independence, chain expansions, and technological advances.
• E-pharmacies Advantages: Offering privacy, discounts, and free shipping, e-pharmacies are becoming increasingly popular.
• Distribution Channels: Hospital pharmacies lead in distribution, benefiting from more patient visits and hospitalizations, especially during the COVID-19 pandemic.
• Market Restraints: Side effects and subsequent product recalls can tarnish brand reputations and slow market growth.
• Emerging Trends: The pandemic has spurred decentralized clinical trials and partnerships between pharmaceutical firms and AI technology companies.
• COVID-19 Influence: Although initially disruptive, the pharmaceutical market quickly adapted, minimizing long-term impacts.
• Regional Dominance: North America held a 52.2% revenue share in 2022, led by industry giants like Walgreens and CVS Health.
• APAC’s Rapid Growth: Asia-Pacific is poised for rapid market expansion, driven by burgeoning pharmaceutical sectors in India and China.
• Strategic Movements: Leading companies focus on R&D, partnerships, and acquisitions to enhance market presence, with key players including Medly Pharmacy, CVS Pharmacy, and Amazon Pharmacy.

Pharmacy Market Statistics

• Global Market Growth
  • The global pharmacy market was valued at USD 1,108 billion in 2022.
  • In 2023, the market is estimated to grow to nearly USD 1,161 billion.
  • For 2024, projections indicate an increase to approximately USD 1,210 billion.
  • By 2025, the market value is expected to reach USD 1,283 billion.
  • Forecasts for 2026 suggest growth to over USD 1,353 billion.
  • The market is projected to grow to USD 1,409 billion in 2027 and USD 1,451 billion by 2028.
  • By 2029, the market is anticipated to reach USD 1,520 billion, increasing further to USD 1,584 billion in 2030.
  • In 2031, the market size is expected to surpass USD 1,660 billion, ultimately reaching USD 1,750 billion by 2032, with a CAGR of 4.8% over the forecast period.
• Regional Investment in Pharmaceuticals
  • The United States dedicates 42.6% of its healthcare budget to the pharmaceutical sector, leading globally.
  • China allocates 7.6%, reflecting its expanding healthcare focus.
  • Japan spends 4.5%, while Germany and France contribute 4% and 2.8%, respectively.
  • Italy and the UK allocate 2.4% and 2.3% of their healthcare budgets, while Canada and Spain contribute 2% and 1.9% each.
  • Brazil matches Spain, with 1.9% of healthcare spending dedicated to pharmaceuticals.
• Company Performance (2022)
  • Pfizer led with USD 100.33 billion in sales, a 19% increase.
  • AbbVie recorded USD 58.05 billion in sales, growing by 3%.
  • Johnson & Johnson and Merck & Co. generated USD 52.6 billion and USD 52.01 billion, respectively.
  • Roche achieved USD 50.38 billion, while Novartis reached USD 50.54 billion, despite a 2% decline.
  • Sanofi’s global sales totaled USD 45.22 billion, with an increase of 7%.
  • AstraZeneca reported USD 44.35 billion, and Bristol-Myers Squibb reached USD 46.16 billion.
  • GSK saw USD 36.15 billion in pharmaceutical and vaccine sales, growing by 11%.
• Sector Insights
  • Specialty Drugs: Represent over 50% of the market, growing at 11.7% in 2023, compared to 7.3% for traditional drugs.
  • Biologics: Accounted for 46% of pharmaceutical spending in 2022, totaling USD 260 billion, with 14% attributed to biosimilars.
  • Pharmacy Benefit Managers: Generated USD 334 billion in revenues in 2023.
  • Generics: Unbranded generics comprised 87.2% of prescriptions but contributed only 8.5% of revenue in 2022.
  • Flu Season: The U.S. experienced an early peak in the 2022-23 flu season, with a significant rise in pediatric cases.
• Technology and Services
  • Hospitalizations surged by 200% for influenza, 60% for RSV, and 51% for COVID-19 since mid-November 2022.
  • 51% of pharmacists reported burnout in 2022, with 75% of community pharmacies struggling to fill technician positions.
  • Collaborative Practice Agreements are active in all U.S. states, empowering pharmacists to manage chronic conditions.
• Vietnam Pharmaceutical Market (2024)
  • The pharmaceutical sector’s profit growth is projected at 8.4%, with revenue expected to rise by 8% and net profit by 6%.
  • Despite revenue growth of 2.5%, Imexpharm’s profits fell by 20.5%, totaling VNĐ61.9 billion.
  • DHG Pharmaceutical reported a 38.4% drop in profits, reaching USD 8.7 million in Q1 2024.
  • Traphaco experienced an 11.6% revenue decline, with a 32% drop in profits to VNĐ54 billion.
  • The Vietnamese market is expected to be valued at USD 7.89 billion, reflecting a 9.1% growth over the previous year.

Emerging Trends

• Increased Use of AI and ML: Artificial Intelligence (AI) and Machine Learning (ML) are transforming the pharmaceutical industry. These technologies are revolutionizing drug discovery and clinical trials by enhancing precision and efficiency. AI enables faster development of personalized medicine while significantly reducing operational costs. This integration streamlines healthcare delivery, improves drug formulations, and enhances therapeutic strategies, leading to better patient outcomes.
• Gene Editing Breakthroughs: Advances in gene editing, particularly using CRISPR technology, are reshaping the treatment of genetic disorders. Targeted therapies, such as Casgevy, offer innovative solutions for conditions like sickle-cell anemia and β-thalassemia. These advancements highlight a shift toward precise and effective healthcare approaches, emphasizing the potential of gene editing to address complex diseases.
• 3D Printing in Drug Manufacturing: The adoption of 3D printing technology is revolutionizing drug manufacturing by enabling customized dosages tailored to individual needs. This enhances treatment efficacy and patient compliance. Furthermore, 3D printing holds promise for bioprinting in regenerative medicine, offering the potential to create tissues and cells for medical recovery and treatment.
• Focus on Curative Therapies: The pharmaceutical sector is increasingly prioritizing curative therapies over symptom management. Breakthroughs in immunotherapies and cell-based treatments, such as CAR-T therapies, have shown remarkable success in curing certain cancers. This trend signifies a transformative shift in healthcare, aiming to provide permanent solutions to chronic and previously untreatable conditions.
• Extended Reality (XR) in Pharmaceutical Research: Extended Reality (XR) tools are enhancing pharmaceutical research and manufacturing. XR facilitates real-time, collaborative interactions, modernizing traditional methodologies and driving innovative drug development. By streamlining workflows and enabling immersive data-rich experiences, XR improves efficiency and outcomes in both research and patient care.

Use Cases in the Pharmacy Sector

• Expanded Clinical Services in Pharmacies: Pharmacies are diversifying by offering a wide range of clinical services, including chronic disease management and specialized care. This expansion not only enhances patient care but also attracts a broader customer base, meeting the growing demand for comprehensive healthcare solutions and driving business growth.
• Integration of Wearable Technology: Wearable devices are transforming pharmacy services by monitoring vital signs and tracking medication adherence. This allows pharmacies to provide personalized and timely interventions, bridging gaps in patient care outside clinical settings. The widespread adoption of wearables strengthens pharmacist-patient connections, improving treatment adherence and health outcomes.
• Automation in Pharmacy Operations: Automation and robotics are redefining the pharmacy industry by handling routine tasks such as medication sorting and inventory management. These technologies enable pharmacists to focus on patient care, boosting operational efficiency and service quality. This shift enhances health management and customer satisfaction.
• Optimized Supply Chain Management: Cutting-edge technologies like blockchain are improving pharmacy supply chains by ensuring product authenticity and quality. By enhancing traceability and transparency, these advancements address counterfeit medication challenges, bolstering patient safety and reinforcing operational reliability and integrity.

Conclusion

The pharmacy sector is undergoing rapid transformation driven by advancements in pharmaceutical technology, increasing healthcare demands, and the rise of personalized and preventive care. Growth is supported by an aging population, the prevalence of chronic diseases, and the expansion of online pharmacies. Emerging technologies, such as AI, gene editing, and 3D printing, are revolutionizing drug discovery, manufacturing, and treatment approaches. Pharmacies are evolving into comprehensive healthcare hubs, offering clinical services, wearables, and personalized customer engagement through automation and digitalization.

Despite challenges like regulatory complexities, high R&D costs, and pricing pressures, opportunities exist in developing regions and digital health solutions. The global market is projected to grow significantly, reaching USD 1,750 billion by 2032 at a 4.8% CAGR, highlighting its pivotal role in modern healthcare delivery.

Discuss your needs with our analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF